INTRODUCTION
The recognition of selenium as an essential element in human metabolism has stimulated the measurement of selenium in biological materials. Many selenium measurements are performed in clinical laboratories in order to establish intake of selenium or guidelines for supplementation, and to monitor environmental and occupational exposures.
In recognition of the importance of analytical accuracy and precision in assessing the biomedical and environmental effects of selenium, the Commission on Toxicology of the IUPAC Clinical Chemistry Division has encouraged the use of freeze-dried (human) body fluids as quality control materials. Thus cooperative studies were conducted to measure total mass concentration of selenium in lots of commercially available freeze-dried human serum and urine to arrive at consensus values (1) . A secondary goal was to assess the performance of the broad range of analytical methods capable of measuring selenium in clinical materials (2, 3, 4) .
In extension of this work, three batches of freeze-dried human whole blood were characterized for total selenium, since this biological fluid was considered to provide a long-term indication of general selenium status. Plasma selenium, which is a commonly used parameter, better reflects short-term changes in selenium status while whole blood selenium is considered to provide a long-term indication of general selenium status.
EXPERIMENTAL Participant laboratories, analytical methods, and general design
Invitations to participate in the study were sent to 91 laboratories in 22 countries selected on the basis of their experience or interest in selenium measurements in biological materials. They were advised of the difficulties in analysing the whole blood matrix and were requested to analyse vials from three batches, each with the natural concentration of selenium. They were also informed that a freeze-dried serum would be included to test performance of the methods for this more common matrix. No constraint was imposed on the analytical method to be used. A total of 39 laboratories agreed to take part in the proposed study. Each were asked to report a minimum of three independent assay results for each batch and had approximately 12 weeks in which to perform the analytical work; 35 laboratories (Appendix A) finally reported results ( 8 in US, 6 in Belgium, 4 in DE, 3 in Finland, 2 in France, 2 in Great Britain, 2 in Italy, 2 in New Zealand, and one each in Norway, Canada, Netherlands, Denmark, Australia, China and Poland). The numbers of laboratories using the various analytical methods are listed in Table 1 .
Materials
The pool materials for the study were made available by NycoMed A / S , Oslo, NorwayBatches 904, 905 and 906 of freeze-dried human whole blood and Batch 105 of freezedried human blood serum presented in vacuum-sealed vials (5 mL and 3 mL nominal values respectively). The maximum acceptable difference in weight in NycoMed's procedure is 2 0.3% with a coefficient of varation of 0.1%. Furthermore, vial to vial consistency within the same batch is assured by identical treatment in all production steps. The materials were prepared from thoroughly tested Norwegian donors (each individual was separately tested by official authorities and found negative for the presence of HBs antigen and HIV antibodies) and were expected to have typical concentrations of endogenous selenium. However the materials were spiked with other elements of interest in biochemistry and toxicology. Typical values for these elements were measured in another IUPAC interlaboratory study (4). Each participant received two vials of each batch, together with three 20-mL polypropylene tubes containing purified sterile water free from contamination with selenium (<O. 1 p&) for reconstitution of the freeze-dried materials. On distributing the vials to participants, no indication was given about the manufacturer, nor was information supplied about Batch 105, which had previously been evaluated for its selenium concentration (2, 3) .
Statistical analysis
Each set of results submitted by the participating laboratories was first investigated for outlier values by Dixon's test (5, 6) . Mean concentrations and variances were calculated for each batch of material and each laboratory. Then, taking all the laboratories results, outlying mean values were excluded either on the basis of the Dixon's test (for serum) or by an extreme-rank sum test for outliers (7) for all the batches of whole blood and serum. Bartlett's test for homoscedasticity (8) was used to test for heterogeneity of variance between all the laboratories and within each group of laboratories that used the same analytical method: exclusion was performed by the chi-square test (8) . Large variances were simultaneously identified by deviation from the upper 3-sigma control limit for the mean deviations of replicate measurements (9) . Data for whole blood were further analysed for repeatability and reproducibility by plotting the results from a pair of pool materials, of similar concentration, analysed together as blind duplicates, in a X-Y graph (9) . This allowed visual comparison of analytical results without elaborate statistical calculations. The dispersion along the 45" line and outside the 95 % confidence circle showed which laboratories had supplied outlying results or were not consistent with regard to repeatability. Figure 1 shows one of the two-sample plots used to exclude some of the outliers.
Exclusion for extreme mean values for each sample was considered when the difference between successive ranked means was higher than 3 %. In this step, analysis of variance (ANOVA), by one-way, two-way or three-way procedures, was performed to test the differences in mean concentrations among the laboratories by the same analytical method and among all the laboratories. These statistical procedures were repeated after removing several laboratories' results on the basis of criteria outlined in the next section. Withinlaboratory and between-laboratories variance components (9) were also estimated to assess the repeatability ( r J and reproducibility ( R J (6) of the analytical methods and to estimate the precision of the reported selenium concentrations for the serum and whole blood materials.
RESULTS AND DISCUSSION

Presentation of the experimental results
Of the 34 laboratories that submitted values for the three batches of whole blood, only 2 (using INAA or RNAA) did not simultaneously report data for serum. The number of replicates for the various assays performed on each batch ranged from 3 to 10. The few laboratories that only reported the mean values [It the standard deviation 0 1 submitted individual results after written request, except for two which did not answer and were therefore excluded from the final calculations. One investigator using EDXRF admitted its inability to analyse the whole blood sample because of difficulties in sample preparations, but values for serum were submitted and were included in the statistical evaluation for serum.
The majority of investigators carried out their measurements on volumetric aliquots of the reconstituted solutions and expressed results as mass concentration of Se (pa). Two laboratories, using INAA and ADIDMS, reported results as mass fraction of Se in wet material (pg/kg), and 6 others, using INAA, RNAA or PIXE, as mass fraction of Se in dry material (pglg=mg/kg). To achieve comparability of the results, these last values were converted to mass concentrations (pa) by multiplying values by experimentally measured volumic mass (or mass density, k a ) . Volumic mass was 1.003 (Batch 105), 1.037 (Batch 904), 1.035 (Batch 905) and 1.035 (Batch 906) glmL, respectively. The reconstituted volumes by addition of the recommended volume of pure water were estimated to be 3.255, 5.722, 5.718 and 5.718 mL, respectively.
Before statistical evaluation, the raw data from all the laboratories were tabulated and sent to all the participants for checking. Two small typing errors were identified and corrected. Tables 2 to 5 assemble individual values for the four materials with the calculated means and standard deviations, after removing the outlying values for the serum and blood materials by Dixon's test (indicated by one asterisk) as well as by the extreme-rank sum test for the whole blood materials. The number of significant figures shown is as reported by the investigators, except in a few cases where we limited it to three or four (one digit after the decimal point). Figures 2 to 5 summarize the raw data and highlight those discarded after statistical evaluation. Two laboratories in particular were unable to obtain satisfactory results because of problems in sample preparation (laboratory 7) or interferences during specific detection (laboratory 26).
Relative performance of methods and exclusion of outlying results
Before assigning selenium concentrations to the serum and whole blood materials, the data were assessed for laboratory performance and method reliability. For this last purpose, the mean concentrations, the within-laboratory and between-laboratory standard deviations and the 95 % confidence intervals were estimated for each method ( Table 6 ). As already observed in similar studies with serum or urine materials (1, 2, 3) , the results (Tables 2 to  6 ) showed considerable variability in the statistical parameters for the different methods. However there was good concordance between ADF and ADH-AAS; sometimes between INAA and ADIDMS, but P E E , and to a lesser extent EAAS and RNAA were erratic or biased. There was also considerable variation in repeatability, but apparently not related to a specific method, except for PEE. Between-laboratory variance was high for EAAS and PIXE, and low for ADF and INAA.
Outliers were excluded separately for the serum and batches of whole blood on the basis of the criteria already described and are further documented in the footnotes to Tables 7  and 8 , i.e. heterogeneity of variance (Bartlett's test) and differences in mean concentrations between laboratories (reproducibility). For serum, all the laboratories using PIXE, RNAA or EDXRF had to be excluded, as well as two of the three laboratories using INAA. The set of data from laboratories using ADIDMS was consistent, as well as the majority of those from laboratories using ADF, EAAS and ADH-AAS. Analytical performances for each group of methods disclosed, after exclusion of outliers, rather better agreement between the means and satisfactory components of variance (Table 6 ). The mean concentration derived from ADIDMS results was slightly lower than from other methods, but it could not be excluded by the ANOVA test for the retained laboratories. Even though IDMS can be the basis of a definitive method, the combined aciddigestiodisotope-dilution mass-spectrometry technique used in this study had the same disadvantage as ADHAAS and ADF (3) in digestion and recovery of the organic bound selenium present in body fluids. The lower concentration by this method may in fact be due to difficulty in conversion of protein-bound selenium to inorganic (tetravalent) selenium.
The inability of laboratories to characterize the batches of whole blood were further compared by a ranking procedure (9) . This served to exclude 4 laboratories, including the two which used PIXE and RNAA (except for Batch 906). The two-sample plots (9) provided information on laboratory precision and relative accuracy that were in good agreement with other criteria, but the performance of laboratories using INAA were judged by this approuch to be satisfactory. The overall pattern of excluded laboratories and methods is presented in Table 8 . Table 9 shows the best estimates of mean concentrations and uncertainties for the four batches of biological materials derived from all of the acceptable results. Concordance between the means for whole blood was less satisfactory than that for serum, but the components of variance were generally better. ADIDMS and RNAA were associated with the lowest mean concentrations. Components of variance were of the same order of magnitude for all the methods, except for some high values associated with ADH-AAS and RNAA.
Estimation of selenium concentrations
The concentration in the serum had already been assessed (2, 3) . In the first study (2), the mean concentration and the 68 % confidence interval for one future observation from g data points W) was estimated to be 90.7 f 6.0 [159]. In the second study (3) 
-term stability of selenium in freeze-dried human serum, but it is not likely that there would be a real increase in concentration. Whether this higher concentration is a less biased estimate of the "true value" is difficult to judge. One distinction between the studies is that the participants in the previous trials had specialized experience in analysis of serum for selenium; however it is unlikely that the differences between the mamx components of serum and whole blood would have influenced the performance of the methods.
The selenium concentrations in the three blood batches were very similar to each other, and to the serum, about 95 pa. Since the different batches were processed from the same batch of blood, this similarity was expected. Finally, the concentrations in whole blood were typical of values usually found in most European countries (but lower than in North America); thus the materials are useful for the analytical control of measurements of selenium in blood. lab having reported only mean and standard deviation. Criteria for exclusion are those of 
